BUZZ-CF PharmTech jumps most on record on new hypertension drug application
Reuters03-16
BUZZ-CF PharmTech jumps most on record on new hypertension drug application
** Shares of China-based inhalation technologies and drugs developer CF PharmTech Inc 2652.HK soar 37.6% to HK$31.64; on course for the biggest one-day pct gain since debut on October 8
** Stock hits the highest since March 10
** Company said China's National Medical Products Administration had accepted investigational new drug $(IND)$ application for its inhalation powder candidate ICF001 to treat pulmonary hypertension and related pulmonary diseases
** ICF001 possesses broad potential to expand into larger patient populations, such as those with pulmonary fibrosis associated with interstitial lung disease, in the future - Co
** YTD, stock down 12.9%, while Hang Seng Biotech Index .HSBIO up 0.3%
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments